Whole-body imaging firm Neko Health raises $700M

Neko Health, a whole-body imaging firm co-founded by Spotify CEO Daniel Ek, has raised $700 million in funding. 

First launched in Sweden in 2023, Neko differs from other imaging startups such as Prenuvo in that it does not use MRI. Rather, the company deploys a “comprehensive,” radiation-free scanner that uses proprietary sensors to assess patient health. 

Neko says it has seen strong demand since its launch, with over 100,000 scans delivered in the U.K. and Sweden and 350,000 individuals on its waitlist. Lightspeed and O.G. Venture Partners led the Series C financing round with participation from several others. 

Ek, a billionaire Swedish entrepreneur behind the popular music streaming service, and colleagues said they’ll use the funds to scale the business, with the first U.S. location coming soon. 

"This funding is a strong vote of confidence in what we set out to do when we opened our first clinic three years ago: a completely new healthcare experience designed to keep people healthy, catch problems early and help prevent disease before it even starts,” Hjalmar Nilsonne, Neko Health CEO and co-founder, said in a July 15 announcement. “With this round, we're taking that mission to the U.S. for the first time, while continuing to invest in the research and technology that make prevention possible at scale.”

Multiple other VC firms also participated in the fundraising round, alongside celebrities such as musician Wil.i.am, Facebook co-founder Mark Zuckerberg, and former tennis star Maria Sharapova. As part of the agreement, David Ofer, with O.G. Venture Partners, will join the board of directors, subject to regulatory approval. This follows a previous $260 million Series B fundraising round in January 2025. 

Neko Health charges between $300 to $400 (USD) for its 60-minute scans in the U.K. and Sweden. The noninvasive assessment uses blood analysis and its own imaging sensors to capture “millions” of health data points. Neko said its scan evaluates skin health (including moles and marks), biomarkers to identify signs of pre-diabetes, blood abnormalities and risk factors linked to metabolic syndrome, stroke and heart attack. Results are delivered on-site within minutes and discussed in-person with a medical professional, “providing members personalized and actionable health findings.” 

The funding announcement comes weeks after Neko also added body composition measures to its service, along with having clinicians review data from wearables. These add-ons are now live across all clinics, “giving members an even more detailed picture of their health.” 

“This is the latest step in a program of continuous innovation, made possible by Neko owning every part of its tech stack in-house,” the company said in its announcement. “This vertical integration is not incidental; it is the foundation that allows Neko Health to control the experience from start to finish, to move faster and to improve continuously,” it added later. 

Since the company launched in 2023, Neko has expanded its footprint across the U.K., with outposts in Manchester, Birmingham and London, alongside a new outpost in Sweden launched last month. About 75% of members now book and prepay for scans for the following year, Neko estimated. 

"Over the past 18 months, Neko Health has demonstrated remarkable innovation and growth, attacking one of the largest markets in the world with breakthrough technology, proven consumer demand, and a clear path to global scale,” Bejul Somaia, global partner with Menlo Park, California-based Lightspeed Venture Partners, said in a statement. “We believe this is one of the most important healthcare companies of our generation, and we're proud to deepen our partnership as they continue to reimagine prevention."

The announcement comes amid growing interest in these preventive imaging scans for healthy people. AI lab Midjourney last month announced it was investing over $74 million to launch its own whole-body scanning chain with plans for the first location in San Francisco later this year.